186 related articles for article (PubMed ID: 17451681)
41. Downregulation of gelsolin family proteins counteracts cancer cell invasion in vitro.
Van den Abbeele A; De Corte V; Van Impe K; Bruyneel E; Boucherie C; Bracke M; Vandekerckhove J; Gettemans J
Cancer Lett; 2007 Sep; 255(1):57-70. PubMed ID: 17493746
[TBL] [Abstract][Full Text] [Related]
42. Overexpression of bone morphogenetic protein 4 enhances the invasiveness of Smad4-deficient human colorectal cancer cells.
Deng H; Ravikumar TS; Yang WL
Cancer Lett; 2009 Aug; 281(2):220-31. PubMed ID: 19321257
[TBL] [Abstract][Full Text] [Related]
43. [Role of Rho GTPase in inhibiting metastatic ability of human prostate cancer cell line PC-3 by omega-3 polyunsaturated fatty acid].
Yi L; Zhang QY; Mi MT
Ai Zheng; 2007 Dec; 26(12):1281-6. PubMed ID: 18076787
[TBL] [Abstract][Full Text] [Related]
44. The MDA-9/Syntenin/IGF1R/STAT3 Axis Directs Prostate Cancer Invasion.
Das SK; Pradhan AK; Bhoopathi P; Talukdar S; Shen XN; Sarkar D; Emdad L; Fisher PB
Cancer Res; 2018 Jun; 78(11):2852-2863. PubMed ID: 29572229
[TBL] [Abstract][Full Text] [Related]
45. MDA-9/syntenin is a key regulator of glioma pathogenesis.
Kegelman TP; Das SK; Hu B; Bacolod MD; Fuller CE; Menezes ME; Emdad L; Dasgupta S; Baldwin AS; Bruce JN; Dent P; Pellecchia M; Sarkar D; Fisher PB
Neuro Oncol; 2014 Jan; 16(1):50-61. PubMed ID: 24305713
[TBL] [Abstract][Full Text] [Related]
46. Kalopanaxsaponin A inhibits PMA-induced invasion by reducing matrix metalloproteinase-9 via PI3K/Akt- and PKCdelta-mediated signaling in MCF-7 human breast cancer cells.
Park SK; Hwang YS; Park KK; Park HJ; Seo JY; Chung WY
Carcinogenesis; 2009 Jul; 30(7):1225-33. PubMed ID: 19420016
[TBL] [Abstract][Full Text] [Related]
47. Inhibition of rho-associated kinase signaling prevents breast cancer metastasis to human bone.
Liu S; Goldstein RH; Scepansky EM; Rosenblatt M
Cancer Res; 2009 Nov; 69(22):8742-51. PubMed ID: 19887617
[TBL] [Abstract][Full Text] [Related]
48. Angiogenic factor thymidine phosphorylase increases cancer cell invasion activity in patients with gastric adenocarcinoma.
Yu EJ; Lee Y; Rha SY; Kim TS; Chung HC; Oh BK; Yang WI; Noh SH; Jeung HC
Mol Cancer Res; 2008 Oct; 6(10):1554-66. PubMed ID: 18922971
[TBL] [Abstract][Full Text] [Related]
49. Identificating 14-3-3 sigma as a lymph node metastasis-related protein in human lung squamous carcinoma.
Li DJ; Deng G; Xiao ZQ; Yao HX; Li C; Peng F; Li MY; Zhang PF; Chen YH; Chen ZC
Cancer Lett; 2009 Jun; 279(1):65-73. PubMed ID: 19231067
[TBL] [Abstract][Full Text] [Related]
50. The transforming functions of PI3-kinase-gamma are linked to disruption of intercellular adhesion and promotion of cancer cell invasion.
Attoub S; De Wever O; Bruyneel E; Mareel M; Gespach C
Ann N Y Acad Sci; 2008 Sep; 1138():204-13. PubMed ID: 18837901
[TBL] [Abstract][Full Text] [Related]
51. Tamoxifen inhibits tumor cell invasion and metastasis in mouse melanoma through suppression of PKC/MEK/ERK and PKC/PI3K/Akt pathways.
Matsuoka H; Tsubaki M; Yamazoe Y; Ogaki M; Satou T; Itoh T; Kusunoki T; Nishida S
Exp Cell Res; 2009 Jul; 315(12):2022-32. PubMed ID: 19393235
[TBL] [Abstract][Full Text] [Related]
52. Differential impact of TGF-beta and EGF on fibroblast differentiation and invasion reciprocally promotes colon cancer cell invasion.
Denys H; Derycke L; Hendrix A; Westbroek W; Gheldof A; Narine K; Pauwels P; Gespach C; Bracke M; De Wever O
Cancer Lett; 2008 Aug; 266(2):263-74. PubMed ID: 18423981
[TBL] [Abstract][Full Text] [Related]
53. Inhibition of invasion and metastasis of hepatocellular carcinoma cells via targeting RhoC in vitro and in vivo.
Wang W; Wu F; Fang F; Tao Y; Yang L
Clin Cancer Res; 2008 Nov; 14(21):6804-12. PubMed ID: 18980974
[TBL] [Abstract][Full Text] [Related]
54. The neuronal glycine transporter 2 interacts with the PDZ domain protein syntenin-1.
Ohno K; Koroll M; El Far O; Scholze P; Gomeza J; Betz H
Mol Cell Neurosci; 2004 Aug; 26(4):518-29. PubMed ID: 15276154
[TBL] [Abstract][Full Text] [Related]
55. mda-9/Syntenin promotes metastasis in human melanoma cells by activating c-Src.
Boukerche H; Su ZZ; Prévot C; Sarkar D; Fisher PB
Proc Natl Acad Sci U S A; 2008 Oct; 105(41):15914-9. PubMed ID: 18832467
[TBL] [Abstract][Full Text] [Related]
56. Suppression of laminin-5 expression leads to increased motility, tumorigenicity, and invasion.
Yuen HW; Ziober AF; Gopal P; Nasrallah I; Falls EM; Meneguzzi G; Ang HQ; Ziober BL
Exp Cell Res; 2005 Sep; 309(1):198-210. PubMed ID: 15963983
[TBL] [Abstract][Full Text] [Related]
57. Mda-9/syntenin is expressed in uveal melanoma and correlates with metastatic progression.
Gangemi R; Mirisola V; Barisione G; Fabbi M; Brizzolara A; Lanza F; Mosci C; Salvi S; Gualco M; Truini M; Angelini G; Boccardo S; Cilli M; Airoldi I; Queirolo P; Jager MJ; Daga A; Pfeffer U; Ferrini S
PLoS One; 2012; 7(1):e29989. PubMed ID: 22267972
[TBL] [Abstract][Full Text] [Related]
58. MDA-9/Syntenin Control.
Philley JV; Kannan A; Dasgupta S
J Cell Physiol; 2016 Mar; 231(3):545-50. PubMed ID: 26291527
[TBL] [Abstract][Full Text] [Related]
59. The characterization of the nuclear dynamics of syntenin-2, a PIP2 binding PDZ protein.
Geeraerts A; Hsiu-Fang F; Zimmermann P; Engelborghs Y
Cytometry A; 2013 Sep; 83(9):866-75. PubMed ID: 23300061
[TBL] [Abstract][Full Text] [Related]
60. Overexpression of syntenin enhances hepatoma cell proliferation and invasion: potential roles in human hepatoma.
Liu X; Zhang X; Lv Y; Xiang J; Shi J
Oncol Rep; 2014 Dec; 32(6):2810-6. PubMed ID: 25242117
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
